| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/01/2014 | US20140121246 Gpr120 receptor agonists and uses thereof |
| 05/01/2014 | US20140121242 Substituted cinnamamide derivative, preparation method and use thereof |
| 05/01/2014 | US20140121236 Compositions and Methods for Treating Myotonic Dystrophy Type 1 |
| 05/01/2014 | US20140121217 Substituted biaryl compounds for inflammation and immune-related uses |
| 05/01/2014 | US20140121213 Voltage-gated sodium channel blockers |
| 05/01/2014 | US20140121210 Asymmetric ureas and medical uses thereof |
| 05/01/2014 | US20140121207 Quinolone compound and pharmaceutical composition |
| 05/01/2014 | US20140119567 Electronic accessory system for a vehicle |
| 04/30/2014 | EP2725026A1 Heterocyclic neoflavonoids with taste masking properties |
| 04/30/2014 | EP2725016A1 Heterocyclic carboxylic acid ester derivative |
| 04/30/2014 | EP2723718A1 Trpm8 antagonists and their use in treatments |
| 04/30/2014 | EP2723717A2 Trpm8 antagonists and their use in treatments |
| 04/30/2014 | EP2723387A1 Cathepsin-binding compounds bound to a carrier and their diagnostic use |
| 04/30/2014 | CN103765624A Light-emitting element, light-emitting device, electronic device, lighting device, and heterocyclic compound |
| 04/30/2014 | CN103764650A Nitrogen-containing heteroaromatic ring compound |
| 04/30/2014 | CN103764649A Method for producing tetrazole-substituted anthranilic acid diamide derivatives by reacting benzoxazinones with amines |
| 04/30/2014 | CN103764641A Partially saturated tricyclic compounds and methods of making and using same |
| 04/30/2014 | CN103764640A ALDH-2 inhibitors in the treatment of addiction |
| 04/30/2014 | CN103764636A Method for manufacturing oxetane compound, method for manufacturing azolylmethylcyclopentanol compound, and intermediate compound |
| 04/30/2014 | CN103764630A Sweet flavor modifier |
| 04/30/2014 | CN103764629A Positive allosteric modulators of nicotinic acetylcholine receptor |
| 04/30/2014 | CN103755690A Yellowing inhibitor of thermal stability type coumarin flourescent brightener and preparation and application thereof |
| 04/30/2014 | CN103755689A Preparation method for prucalopride degradation impurities |
| 04/30/2014 | CN103755688A Preparation method for afatinib compound |
| 04/30/2014 | CN103755647A C2-bit derivative of 4(3H)-quinazolinone and preparation method and application thereof |
| 04/30/2014 | CN102336746B Preparation method and anti-cancer action of novel diacid solanesol alkyl tegafur diesters |
| 04/30/2014 | CN101633655B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 04/29/2014 | US8710244 Dyes and methods of marking biological material |
| 04/29/2014 | US8710239 Process for preparing synthetic intermediates of peripherally-selective inhibitors of dopamine-β-hydroxylase involving catalytic asymmetric hydrogenation |
| 04/29/2014 | US8710221 Process and intermediates for preparing lapatinib |
| 04/29/2014 | US8710198 Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof |
| 04/29/2014 | US8710097 Flavonoid dimers and methods of making and using such |
| 04/29/2014 | US8710070 Opioid-ketamine and norketamine codrug combinations for pain management |
| 04/29/2014 | US8710069 Opioid-nornicotine codrugs combinations for pain management |
| 04/29/2014 | CA2768700C Processes and intermediates for the preparation of aspartic acetal caspase inhibitors |
| 04/29/2014 | CA2681206C 8-(heteroarylmethoxy)quinoline compounds as bradykinin b2 receptor modulators |
| 04/29/2014 | CA2655573C Therapeutic or prophylactic agent for multiple sclerosis |
| 04/29/2014 | CA2624307C Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 04/29/2014 | CA2573976C Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/29/2014 | CA2570873C Pyrimidine urea derivatives as kinase inhibitors |
| 04/29/2014 | CA2554809C Novel n-alkyl thiourea-and thioamide-substituted imidazolyl inhibitors and glutaminyl cyclase |
| 04/29/2014 | CA2524009C Use of effectors of glutaminyl and glutamate cyclases |
| 04/24/2014 | WO2014063168A1 Heterocycle-bisamide inhibitors of scavenger receptor bl |
| 04/24/2014 | WO2014063033A2 Novel probes and targeting comounds for mitochondria |
| 04/24/2014 | WO2014062938A1 Rory modulators |
| 04/24/2014 | WO2014062732A1 Substituted benzene compounds |
| 04/24/2014 | WO2014061961A1 Organic electroluminescence compounds and organic electroluminescence device comprising the same |
| 04/24/2014 | WO2014061031A1 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders |
| 04/24/2014 | WO2014061000A1 Process for the preparation of vilazodone or pharmaceutically acceptable salt thereof |
| 04/24/2014 | WO2014060623A1 Functionalised and immunoreactive derivatives for the fungicide fludioxonil |
| 04/24/2014 | WO2014060493A2 N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group |
| 04/24/2014 | WO2014060386A1 Indol-amide compounds as beta-amyloid inhbitors |
| 04/24/2014 | WO2014059956A1 A method of producing the key intermediate of lapatinib synthesis |
| 04/24/2014 | US20140114068 Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases |
| 04/24/2014 | US20140113935 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
| 04/24/2014 | US20140113907 Pyridylaminoacetic acid compound |
| 04/24/2014 | US20140113897 Compositions and methods for modulating the activity of epstein-barr nuclear antigen 1 |
| 04/24/2014 | US20140113815 Azole derivative, method for producing azole derivative, and intermediate compound |
| 04/24/2014 | US20140113005 Compounds useful as inhibitors of atr kinase |
| 04/23/2014 | EP2722329A1 Indol-amide compounds as beta-amyloid inhbitors |
| 04/23/2014 | EP2721026A1 Phosphate esters of gyrase and topoisomerase inhibitors |
| 04/23/2014 | EP2721025A1 New selective ccr2 antagonists |
| 04/23/2014 | EP2721019A1 Therapeutically active compositions and their methods of use |
| 04/23/2014 | EP2721014A2 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation |
| 04/23/2014 | EP2721011A1 Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto |
| 04/23/2014 | EP2721008A1 Hydroxy substituted isoquinolinone derivatives |
| 04/23/2014 | EP2721007A1 Cyclohexyl isoquinolinone compounds |
| 04/23/2014 | CN103748091A Analyte detection using near-infrared fluorophores |
| 04/23/2014 | CN103748090A Glycoside derivatives and their uses for the treatment of diabetes |
| 04/23/2014 | CN103748073A Novel soft PDE4 inhibitors |
| 04/23/2014 | CN103739597A 14-deoxy-14,15-didehydro andrographolide derivatives and medicine composition and application thereof |
| 04/23/2014 | CN103739596A Quinazoline derivative used for cardio cerebrovascular diseases |
| 04/23/2014 | CN103739595A Compounds and compositions as protein kinase inhibitors |
| 04/23/2014 | CN103739550A 2, 3-dimethyl-6-urea-2H-indazole compound and preparation method and application thereof |
| 04/23/2014 | CN102827368B Biomass-based organic polymer porous material and synthesizing method thereof |
| 04/23/2014 | CN102388038B Benzofuranyl derivatives used as glucokinase inhibitors |
| 04/23/2014 | CN101910131B Carboxamide, sulfonamide and amine compounds and usagmethod thereof |
| 04/23/2014 | CN101723893B 2,3-disubstituted-2,3-dihydro quinoline ketone chiral compound as well as preparation method and application thereof |
| 04/22/2014 | US8703945 Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin |
| 04/22/2014 | US8703938 Hepatitis C virus inhibitors |
| 04/22/2014 | US8703810 Estrogen receptor modulators and uses thereof |
| 04/22/2014 | US8703761 Organic compounds |
| 04/22/2014 | US8703758 Bicyclic compound |
| 04/22/2014 | US8703721 Arylalkylamine compound and process for preparing the same |
| 04/22/2014 | CA2781292C Novel spiropiperidine compounds |
| 04/22/2014 | CA2659696C 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 04/22/2014 | CA2612227C Pyrimidine compounds |
| 04/22/2014 | CA2611295C Isoquinoline derivatives as inhibitors of rho-kinase |
| 04/17/2014 | WO2014059214A1 Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 04/17/2014 | WO2014058037A1 Pyrone compounds and herbicides comprising the same |
| 04/17/2014 | WO2014057844A1 Method for producing cycloalkanol derivative, and method for producing azole derivative |
| 04/17/2014 | WO2014057772A1 Novel pyrazole derivative |
| 04/17/2014 | WO2014057685A1 Organic electroluminescent element |
| 04/17/2014 | WO2014057103A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 04/17/2014 | WO2014057078A1 Benzamides |
| 04/17/2014 | WO2014056771A1 New pyrrolidine derivatives and their use as acetyl-coa carboxylase inhibitors |
| 04/17/2014 | WO2014056083A1 Kinase inhibitors and method of treating cancer with same |
| 04/17/2014 | WO2013064461A3 Compounds with nematicidal activity |
| 04/17/2014 | US20140107340 Benzamides |
| 04/17/2014 | US20140107339 Substituted 3-hydroxy-delta-lactones from epoxides |